Poison control reports show increase in adverse exposures to drugs for depression

Serious outcomes after overdose or unintentional exposure to medications used to treat depression rose steadily in the period from 2000 to 2014, with both older and newer drugs contributing to the problem, according to a new study. The study's lead author suggests that many clinicians remain largely unaware of the relative dangers of these medications, including a selective serotonin reuptake inhibitor (SSRI) class that once was believed to result in virtually no morbidity or mortality. Study results were published online Jan. 31 in the American Journal of Psychiatry.
Source: The Brown University Psychopharmacology Update - Category: Psychiatry Tags: Depression Treatment Source Type: research